Cartesian Therapeutics Correlations

RNAC Stock   7.84  0.29  3.84%   
The current 90-days correlation between Cartesian Therapeutics and Eupraxia Pharmaceuticals Common is 0.03 (i.e., Significant diversification). The correlation of Cartesian Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cartesian Therapeutics Correlation With Market

Good diversification

The correlation between Cartesian Therapeutics and DJI is -0.2 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cartesian Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Cartesian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Cartesian Stock refer to our How to Trade Cartesian Stock guide.

Moving against Cartesian Stock

  0.55CMB Cambium BioPairCorr
  0.37EQ EquilliumPairCorr
  0.34JUMP Leveljump Healthcare Corp Earnings Call This WeekPairCorr
  0.49PYC Physiomics Plc Earnings Call This WeekPairCorr
  0.316C1 CytomX Therapeutics Earnings Call Next WeekPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GNFTEPRX
IVAEPRX
GNFTIVA
FENCNAUT
AVTXOBIO
AVTXMDWD
  

High negative correlations

GNFTAVTX
AVTXIVA
AVTXEPRX
GNFTOBIO
OBIOIVA
OBIOEPRX

Risk-Adjusted Indicators

There is a big difference between Cartesian Stock performing well and Cartesian Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cartesian Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
EPRX  2.80  0.38  0.13  0.82  2.45 
 6.71 
 24.61 
IVA  3.23  0.80  0.21  4.12  2.99 
 9.41 
 20.30 
NAUT  4.22  0.48  0.09  0.86  4.27 
 9.29 
 27.53 
OBIO  3.57 (0.14)(0.01) 0.03  4.02 
 10.17 
 22.05 
MDWD  1.94 (0.09)(0.03) 0.00  2.84 
 3.79 
 14.07 
AARD  3.59  0.25  0.10  0.18  3.98 
 9.35 
 38.95 
FENC  2.01  0.00 (0.01) 0.09  2.70 
 4.19 
 10.44 
AVTX  3.70 (0.13) 0.00 (0.28) 0.00 
 6.64 
 21.73 
NTHI  4.88  0.42  0.10  0.23  5.38 
 9.99 
 41.97 
GNFT  3.17  0.59  0.11  1.23  3.86 
 7.34 
 25.18 

Cartesian Therapeutics Corporate Management

Emily EnglishSVP ManufacturingProfile
Peter MDChief OfficerProfile
Milos MDChief OfficerProfile
June SeymourChief OfficerProfile
Blaine DavisChief OfficerProfile
Matthew JDGeneral SecretaryProfile
Metin MDChief OfficerProfile